Epilepsy Clinical Trials

Find Epilepsy Clinical Trials Near You

Noninvasive Temporal Interference Stimulation for the Treatment of Drug Resistant Epilepsy

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This single-center prospective study aims to investigate the treatment efficacy of temporal interference (TI) in drug-resistant epilepsy patients aged 6-60.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 6
Maximum Age: 60
Healthy Volunteers: f
View:

• Participants are between the ages of 6 -60 years of age.

• Patients must be clinically evaluated as having drug resistant epilepsy.

• Persistence of disabling seizures at least 2 times per months or greater.

• Informed consent signed.

Locations
Other Locations
China
Xuanwu Hospital, Capital Medical University
RECRUITING
Beijing
Contact Information
Primary
Liankun Ren, MD
renlk2022@outlook.com
+86 13681576621
Time Frame
Start Date: 2024-11-30
Estimated Completion Date: 2028-11-30
Participants
Target number of participants: 30
Treatments
Experimental: Temporal Interference
The investigators perform temporal interference (TI) stimulation to patients with drug-resistant epilepsy. They observe clinical manifestations before, during, and after stimulation to investigate the efficiency of TI.
Related Therapeutic Areas
Sponsors
Leads: Xuanwu Hospital, Beijing

This content was sourced from clinicaltrials.gov

Similar Clinical Trials

We couldn't find any related articles check for more on the main search page.